Literature DB >> 20508178

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Michael Pignone1, Mark J Alberts, John A Colwell, Mary Cushman, Silvio E Inzucchi, Debabrata Mukherjee, Robert S Rosenson, Craig D Williams, Peter W Wilson, M Sue Kirkman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508178     DOI: 10.1161/CIR.0b013e3181e3b133

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  61 in total

Review 1.  Type 2 diabetes and cardiovascular disease: what next?

Authors:  Joshua J Joseph; Sherita Hill Golden
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

2.  Aspirin for primary prevention: what's a clinician to do?

Authors:  Mitchell A Psotka; Kirsten E Fleischmann
Journal:  J Gen Intern Med       Date:  2015-02       Impact factor: 5.128

Review 3.  Antiplatelet treatment in essential hypertension: where do we stand?

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Stella Douma
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

4.  Toward a guided approach to platelet activation in diabetes.

Authors:  M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

5.  Diabetes: Does aspirin increase the risk of major bleeds?

Authors:  Carlo Patrono
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

6.  Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines.

Authors:  Jeremy B Sussman; Sandeep Vijan; HwaJung Choi; Rodney A Hayward
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-04-12

7.  Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis.

Authors:  Safi U Khan; Zain Ul Abideen Asad; Muhammad U Khan; Swapna Talluri; Farman Ali; Muhammad Shahzeb Khan; Ahmad N Lone; Farouk Mookadam; Richard A Krasuski; Edo Kaluski
Journal:  Eur J Prev Cardiol       Date:  2019-01-30       Impact factor: 7.804

Review 8.  Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Authors:  Mohammed E Al-Sofiani; Robert Derenbecker; Michael Quartuccio; Rita R Kalyani
Journal:  Curr Diab Rep       Date:  2019-09-23       Impact factor: 4.810

Review 9.  Subclinical cardiovascular disease assessment in persons with diabetes.

Authors:  Haider Javed Warraich; Khurram Nasir
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 10.  The role of aspirin in the prevention of cardiovascular disease.

Authors:  Sunitha V Ittaman; Jeffrey J VanWormer; Shereif H Rezkalla
Journal:  Clin Med Res       Date:  2014-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.